Unknown

Dataset Information

0

Discovery of allosteric modulators of factor XIa by targeting hydrophobic domains adjacent to its heparin-binding site.


ABSTRACT: To discover promising sulfated allosteric modulators (SAMs) of glycosaminoglycan-binding proteins (GBPs), such as human factor XIa (FXIa), we screened a library of 26 synthetic, sulfated quinazolin-4(3H)-ones (QAOs) resulting in the identification of six molecules that reduced the Vmax of substrate hydrolysis without influencing the KM. Mutagenesis of residues of the heparin-binding site (HBS) of FXIa introduced a nearly 5-fold loss in inhibition potency supporting recognition of an allosteric site. Fluorescence studies showed a sigmoidal binding profile indicating highly cooperative binding. Competition with a positively charged, heparin-binding polymer did not fully nullify inhibition suggesting importance of hydrophobic forces to binding. This discovery suggests the operation of a dual-element recognition process, which relies on an initial Coulombic attraction of anionic SAMs to the cationic HBS of FXIa that forms a locked complex through tight interaction with an adjacent hydrophobic patch. The dual-element strategy may be widely applicable for discovering SAMs of other GBPs.

SUBMITTER: Karuturi R 

PROVIDER: S-EPMC3625964 | biostudies-literature | 2013 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Discovery of allosteric modulators of factor XIa by targeting hydrophobic domains adjacent to its heparin-binding site.

Karuturi Rajesh R   Al-Horani Rami A RA   Mehta Shrenik C SC   Gailani David D   Desai Umesh R UR  

Journal of medicinal chemistry 20130318 6


To discover promising sulfated allosteric modulators (SAMs) of glycosaminoglycan-binding proteins (GBPs), such as human factor XIa (FXIa), we screened a library of 26 synthetic, sulfated quinazolin-4(3H)-ones (QAOs) resulting in the identification of six molecules that reduced the Vmax of substrate hydrolysis without influencing the KM. Mutagenesis of residues of the heparin-binding site (HBS) of FXIa introduced a nearly 5-fold loss in inhibition potency supporting recognition of an allosteric s  ...[more]

Similar Datasets

| S-EPMC3696790 | biostudies-literature
| S-EPMC8301998 | biostudies-literature
| S-EPMC2654577 | biostudies-literature
| S-EPMC4007895 | biostudies-other
| S-EPMC5900322 | biostudies-literature
| S-EPMC8233869 | biostudies-literature
| S-EPMC4317055 | biostudies-literature
| S-EPMC8733272 | biostudies-literature
| S-EPMC8146373 | biostudies-literature
| S-EPMC9920195 | biostudies-literature